GE HealthCare Technologies PCS — Cost of Sales decreased by 10.4% to $481.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $481.00M to $481.00M. Over 3 years (FY 2022 to FY 2025), PCS — Cost of Sales shows an upward trend with a 3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to revenue suggests improved manufacturing efficiency or lower input costs.
Includes the direct costs attributable to the production and delivery of Patient Care Solutions products, such as raw ma...
Commonly reported as Cost of Goods Sold (COGS) in industrial and medical device segments.
gehc_segment_pcs_cost_of_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $459.75M | $459.75M | $459.75M | $459.75M | $472.50M | $472.50M | $472.50M | $472.50M | $460.00M | $480.00M | $486.00M | $504.00M | $481.00M | $507.00M | $503.00M | $537.00M | $481.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.8% | +0.0% | +0.0% | +0.0% | -2.6% | +4.3% | +1.3% | +3.7% | -4.6% | +5.4% | -0.8% | +6.8% | -10.4% |
| YoY Change | — | — | — | — | +2.8% | +2.8% | +2.8% | +2.8% | -2.6% | +1.6% | +2.9% | +6.7% | +4.6% | +5.6% | +3.5% | +6.5% | +0.0% |